Case Study: Exploring Novel Antibody-Drug Conjugates Storming Through the Clinic

Time: 4:30 pm
day: Conference Day One


  • Following a record-breaking year for ADCs entering the clinic, this session will focus on some of the most exciting clinical candidates and positive Phase I data
  • Discussing the key preclinical data indicative of future clinical success
  • Outlining different clinical trial designs, with the disadvantages and advantages of each design